Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Ventas (VTR)

Ventas raises 2025 FFO guidance as second-quarter normalized FFO rises 9%

Positive Impact 4 of 5 earnings Written later

Ventas reported second-quarter 2025 normalized FFO of $0.87 per share, up 9% from $0.80 a year earlier, and attributable net income of $0.15 per share, up from $0.05. The REIT raised its full-year 2025 normalized FFO per share guidance midpoint to $3.44 from $3.41 and increased its 2025 investment volume expectation to $2 billion from $1.5 billion, which points to higher expected earnings for shareholders.

Key points

  • Q2 2025 normalized FFO per share was $0.87, compared with $0.80 in Q2 2024; Nareit FFO per share was $0.86, compared with $0.77.
  • Full-year 2025 normalized FFO per share guidance range was raised to $3.41 to $3.46 from $3.36 to $3.46, with the midpoint at $3.44 versus $3.41 previously.
  • Senior housing operating portfolio same-store cash NOI grew 13% year over year in the second quarter.
  • 2025 investment volume expectation was increased to $2 billion from $1.5 billion; liquidity was $4.7 billion as of June 30, 2025.

The filing

CompanyVentas (VTR)
Form8-K, current report
Filed with the SECJul 30, 2025, 4:30 PM ET
Accession number0000740260-25-000228

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.